FIELD: transplantation surgery. SUBSTANCE: preservative solution for renal transplants (pH 7.25-7.30) contains, g/l±5%: sodium chloride 0.7, sodium succinate 0.5, monopotassium phosphate 1.04, dipotassium phosphate 3.7, sodium bicarbonate 0.8, magnesium aspartate 0.1, dimexide 5.0, potassium acetate 0.2, thiotriazoline 5.0, glucose 20.0, heparin 0.025, distilled water to 1 l. EFFECT: increased efficiency of pharmaceutical protection of transplant. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CONSERVATIVE TREATMENT OF CHILDREN WITH RENAL DYSPLASIA | 1997 |
|
RU2150941C1 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| METHOD OF TREATING OCCLUDING INJURIES OF CORNEAL AND OPTIC-NERVE VESSELS | 1995 |
|
RU2122384C1 |
| COMPOSITION FOR PRESERVATION OF DONOR KIDNEYS | 0 |
|
SU938873A1 |
| METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| 1-(β-PHENYLETHYL)-4-(PARA-DIMETHYLAMINOBENZYLIDENEAMINO)- -1,2,4-TRIAZOLIUM BROMIDE SHOWING ANTIOXIDANT, ANTI-ISCHEMIC, β-ADRENOBLOCKING, UTEROTONIC AND DECREASING INTRAOCULAR PRESSURE EFFECTS | 1997 |
|
RU2136669C1 |
| COMPOSITION FOR PRESERVING KIDNEY | 0 |
|
SU1074471A1 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
